*Correspondence: Maria Teresa Baltazar, [email protected] Present address: Danilo Basili, Socit des Produits Nestl S.A., Nestl Research, Lausanne, Switzerland Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Some sort of eye disorder 7
Peak fits this reader profile: Cash-pay patients with no GLP-1 insurance coverage Buyers who want tirzepatide at the lowest available price Patients who want the fastest possible start Those comfortable with credentialed compounded medication Patients who bounced from another provider and want fast re-entry Hims fits this reader profile: Buyers who want FDA-approved branded medication only Needle-averse patients who want the Wegovy pill Patients who want coaching, an app, and a community, not just a script Those who value an established brand and are willing to pay for it Direct recommendation for the cortisol or perimenopause reader: tirzepatide through Peak is the lowest-friction cash-pay route to the better-evidenced molecule
The testosterone recovery benefit, driven by greater total fat loss, also favors tirzepatide in male populations